NPI: 1952679771 · TUCSON, AZ 85716 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 12/07/2011
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 12/07/2011 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 13,659 | $385K |
| 2019 | 13,673 | $461K |
| 2020 | 20,451 | $683K |
| 2021 | 19,618 | $767K |
| 2022 | 21,350 | $675K |
| 2023 | 12,233 | $463K |
| 2024 | 5,712 | $399K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 35,611 | 2,913 | $2.82M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 17,582 | 1,646 | $466K |
| 90945 | 14,828 | 472 | $311K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 428 | 263 | $186K |
| J1756 | Injection, iron sucrose, 1 mg | 5,880 | 1,565 | $51K |
| A4657 | Syringe, with or without needle, each | 13,747 | 1,992 | $855.26 |
| J1270 | Injection, doxercalciferol, 1 mcg | 9,236 | 776 | $20.40 |
| G0008 | Administration of influenza virus vaccine | 165 | 137 | $0.00 |
| 83550 | 174 | 147 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 90 | 44 | $0.00 |
| 90674 | 109 | 81 | $0.00 | |
| 82728 | 173 | 148 | $0.00 | |
| 85048 | 343 | 294 | $0.00 | |
| 83540 | 174 | 147 | $0.00 | |
| J1644 | Injection, heparin sodium, per 1000 units | 7,545 | 573 | $0.00 |
| 82108 | 93 | 80 | $0.00 | |
| 85041 | 345 | 296 | $0.00 | |
| 83970 | 173 | 147 | $0.00 |